(Reuters) - Eli Lilly on Friday was cleared of liability in the first trial involving claims that its antidepressant Cymbalta caused severe withdrawal symptoms, including suicidal thoughts and ...

The Food and Drug Administration (FDA) has announced a significant recall affecting over 550,000 bottles of duloxetine delayed-release capsules. This recall comes as a result of elevated levels of a ...

TORONTO (CTV Network) — A new study has found that some common antidepressant medications have a higher risk of causing distressing and sometimes disabling withdrawal symptoms when patients try to ...

An antidepressant medication named duloxetine has been recalled by the U.S. Food and Drug Administration (FDA) due to the presence of carcinogenic chemicals. The drug was voluntarily recalled by a New ...

A popular antidepressant, often known by the brand name Cymbalta, was recalled last week due to the presence of a potentially cancer-causing chemical. More than 233,000 bottles of duloxetine capsules ...

Thousands of bottles of antidepressants have been recalled across the U.S. after they were found to contain levels of a potentially cancer-causing chemical above the acceptable limit as set out by the ...

The U.S. Food and Drug Administration has recalled over 7,000 bottles of the antidepressant duloxetine, which is commonly sold under the name Cymbalta. According to the FDA, the drug was recalled ...

Oct. 18, 2005 — The U.S. Food and Drug Administration (FDA) and Eli Lilly & Co. have warned healthcare professionals regarding the increased risk of hepatotoxicity associated with use of duloxetine ...

Over 7,100 bottles of Duloxetine were voluntarily recalled by the medication's company beginning Oct. 10 The U.S. Food and ...

The U.S. Food and Drug Administration announced a Class II recall for more than 7,100 bottles of Duloxetine — a generic antidepressant for Cymbalta — due to a cancerous chemical. A voluntary recall ...